Compounded GLP-1 Assessment
Best Compounded GLP-1 Providers (2026): Ranked by Pharmacy Transparency
Comparative analysis • Last reviewed August 5, 2026
Executive Summary
Compounded GLP-1 programs all sell roughly the same thing at roughly the same price, so the useful way to rank them is not by marketing claims but by disclosure. A compounded medication is only as trustworthy as the pharmacy that made it, and most providers will not tell you which pharmacy that is.
This ranking weights three things heavily: whether the provider names its pharmacy partners and their accreditation, whether batches are independently tested with a Certificate of Analysis you can see, and whether the provider states plainly on its own site that compounded medications are not FDA-approved. Providers that do all three rank above providers that are merely cheap.
Section 1: Ranked by Transparency
| # | Provider | Rating | Published price | Why it ranks here |
|---|---|---|---|---|
| 1 | Cora HealthBest overall | 9 | Compounded semaglutide $99–$175/mo; tirzepatide $135–$225/mo | Names Hallandale Pharmacy (PCAB-accredited, USP 797 compliant, operating since 2003) and VialsRx (PCAB-accredited), identifies the filling pharmacy on every medication label, and publishes full credentialing plus its complete price ladder. |
| 2 | Precision TelemedBest testing disclosure | 8.9 | Compounded semaglutide from $139.99/mo; tirzepatide $199/mo | Names Rush Pharmacy and Greenwich Pharmacy, states every compound is tested by an independent accredited lab with a Certificate of Analysis for purity, potency, sterility, and endotoxins, and publishes clinician NPI numbers. |
| 3 | OrderlyMedsBest bundled value | 8.8 | Compounded GLP-1 from $149/mo; GLP-1/GIP from $299/mo | Names SmartPharmaRx, Casa, and PerfectRx/PerfectionRx, states each batch is tested for sterility and potency, and includes dietitian meal plans and a fitness app in the price. |
| 4 | NavioMDBest fulfillment clarity | 8.3 | Transparent pricing published during intake — insurance-free | Names The Pharmacy Hub as its exclusive accredited fulfillment partner, handles both compounded and branded medications, and discloses its two state exclusions up front. |
| 5 | 24hrDocClearest pricing | 8.4 | Compounded semaglutide from $149/mo (sale price) | Publishes sale and regular pricing for injectable semaglutide, oral semaglutide, and tirzepatide separately. Explicitly states it is not a pharmacy and explains compounded status in its own FAQ. |
| 6 | Fitish RXBest dosing flexibility | 8.4 | Compounded semaglutide $219/mo; microdose $179/mo | Publishes both a full-dose and a microdose lane with separate prices, and states plainly that compounded products are not FDA-approved while noting approved alternatives exist. |
| 7 | ShapelyBest safety net | 8.7 | Insurance copays typically ~$25/mo; compounded from $99/mo | Only reaches compounded medication after exhausting insurance and manufacturer self-pay options, which is the clinically conservative sequence. |
| 8 | Hello DoseBest microdosing program | 8 | Semaglutide $495/mo; tirzepatide $695/mo; microdosing from $395/mo | Explicit microdosing tiers with NP oversight and coaching included, though it does not publicly name its pharmacy partners. |
| 9 | Good Life MedsBest refund guarantee | 7.8 | All-inclusive pricing shown at plan selection | Publishes a clear commitment to full refund of all costs if a provider declines to prescribe — rare in this category — though it does not name pharmacies. |
| 10 | HelimedsLowest entry friction | 7.7 | Program pricing shown after the free consultation | Free consultation and five-minute pre-approval, with clear disclosure of compounded status, but no published price ladder or named pharmacies. |
Prices are what each provider published as of the review date and change frequently. Confirm current pricing on the provider's own site before enrolling.
Section 2: The Pharmacies Behind the Programs
Several of the compounding pharmacies that supply these telehealth platforms are reviewed on this site directly. If your provider names its pharmacy, you can look up what we found.
Section 3: How to Evaluate a Compounded Program
Step 1: Get the pharmacy name in writing
If a provider will not name the pharmacy compounding your medication, you cannot check its accreditation, inspection history, or whether it has been the subject of FDA warning letters. Providers that name theirs — Cora Health, Precision Telemed, OrderlyMeds, NavioMD — are giving you something you can verify.
Step 2: Ask for the Certificate of Analysis
Independent lab testing for purity, potency, sterility, and endotoxin levels is the difference between a claim and evidence. Precision Telemed publishes that it tests every compound through an accredited third-party lab. Ask any provider you are considering whether you can see a CofA for your batch.
Step 3: Get the full price ladder
Some programs charge the same at every dose; others escalate. A $99 entry price that becomes $250 at your maintenance dose is a different product financially. Cora Health and Precision Telemed both publish complete ladders.
Step 4: Find out what happens if you are declined
Very few providers publish this. Good Life Meds states you receive a full refund of all costs incurred if you are not prescribed. Hello Alpha states the opposite in one scenario — that a denied prior authorization does not entitle you to a plan fee refund. Know which you are signing up for.
Step 5: Check the FDA-approved alternative first
Since Eli Lilly and Novo Nordisk cut self-pay prices, brand-name medication is closer to compounded pricing than it has ever been. Compare against LillyDirect and NovoCare Pharmacy before deciding the compounded route is the only affordable one.
Section 4: Risks You Should Understand
- !No FDA review. Compounded medications are not evaluated by the FDA for safety, effectiveness, or manufacturing quality. That is not a technicality — it is the core difference from an approved product.
- !Fraudulent labels. The FDA reports fraudulent compounded semaglutide and tirzepatide where the compounding pharmacy named on the label does not exist, and other cases where the label carries the name of a licensed pharmacy that did not make the product. This is precisely why naming the pharmacy — and checking it — matters.
- !Salt forms. The FDA states that semaglutide sodium and semaglutide acetate are different active ingredients from the one in approved drugs, and that it is not aware of any lawful basis for their use in compounding. In May 2025, Endpoints News reported allegations that one large compounder had used salt forms. Ask your prescriber which form you are getting.
- !Dosing errors. The FDA has received multiple adverse event reports, some requiring hospitalization, that may relate to dosing errors with compounded injectable semaglutide — a risk that is higher with vials than with pre-dosed pens.
- !Variable potency. Potency testing is not federally mandated for 503A compounders in the way it is for approved drug manufacturing. Pharmacies that test voluntarily and publish results are meaningfully more trustworthy.
- !Regulatory volatility. The compounded GLP-1 landscape has changed repeatedly since 2024. A program available today may narrow its offering tomorrow, as Strive Pharmacy did with compounded oral semaglutide.
- !Insurance will not help. Compounded medications are generally not covered, so there is no fallback if the price rises.
Frequently Asked Questions
Are compounded GLP-1 medications FDA-approved?
No. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or manufacturing quality. They are prepared by state-licensed pharmacies against a valid prescription when a licensed prescriber determines a compounded preparation is clinically appropriate for a specific patient. Every reputable provider on this page states that plainly on its own site.
What is the difference between a 503A and 503B pharmacy?
A 503A pharmacy compounds against patient-specific prescriptions and is licensed by state boards of pharmacy. A 503B outsourcing facility can produce larger batches without patient-specific prescriptions and is subject to FDA inspection and current good manufacturing practice requirements. Most telehealth GLP-1 programs use 503A pharmacies. Empower Pharmacy operates both.
How do I know my compounded medication is what it claims to be?
Ask three questions: which pharmacy compounded it, what accreditation that pharmacy holds (PCAB is the most meaningful), and whether an independent lab tested the batch. Precision Telemed publishes Certificates of Analysis covering purity, potency, sterility, and endotoxin levels. Cora Health and OrderlyMeds name their pharmacies and describe their testing. Many providers do none of this.
Why is compounded semaglutide so much cheaper than Wegovy?
Compounded preparations do not carry the research, clinical trial, and regulatory costs built into a brand-name drug's price, and they are not sold through the same distribution and rebate structure. That is the honest explanation for the price gap — and also the honest explanation for why the regulatory assurances are different.
Did compounded GLP-1s become illegal after the shortage ended?
Not illegal, but considerably more constrained. The FDA's shortage-driven enforcement discretion for compounded tirzepatide and semaglutide phased out in March 2025. Compounding continues under standard 503A and 503B rules where a prescriber determines a compounded preparation is clinically justified for a particular patient. Some pharmacies have narrowed what they will make as a result.